Search Results - ige

Tremelimumab Biosimilar, Endotoxin 0.05 EUmg C037P.05 Syd Labs

Tremelimumab Biosimilar, Endotoxin 0.05 EU/mg | C037P.05

Tremelimumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Tremelimumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...

Efalizumab Biosimilar, Endotoxin 0.05 EUmg C045P.05 Syd Labs

Efalizumab Biosimilar, Endotoxin 0.05 EU/mg | C045P.05

Efalizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Efalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...

Ipilimumab Biosimilar, Human IgG4 S228P Mutant C050P.NA Syd Labs

Ipilimumab Biosimilar, Human IgG4 S228P Mutant | C050P.NA

Ipilimumab Biosimilar, N297A Mutant. The research grade Ipilimumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally...

Omalizumab Biosimilar C020P.NA Syd Labs

Omalizumab Biosimilar, N297A Mutant | C020P.NA

Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...

Palivizumab Biosimilar C021P.NA Syd Labs

Palivizumab Biosimilar, N297A Mutant | C021P.NA

Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1...

Palivizumab Biosimilar C021P.05 Syd Labs

Palivizumab Biosimilar, Endotoxin 0.05 EU/mg | C021P.05

Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...